FDA Approves Almirall’s Klisyri® (tirbanibulin) for the Treatment of Actinic Keratosis on Expanded Area of Face or Scalp up to 100 cm2
Business Wire
MALVERN, Pa.--(BUSINESS WIRE)--Almirall, a global pharmaceutical company dedicated to medical dermatology, announced today that the..